Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.21873/invivo.12138 http://scihub22266oqcxt.onion/10.21873/invivo.12138 32871850!7652506!32871850     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       In+Vivo 2020 ; 34 (5): 3039-3045 Nephropedia Template TP {{tp|p=32871850|t=2020. Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece |pdf=|usr=}}{{32871850}} gab.com Text Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece JO: In Vivo http://www.kidney.de/pget.php?&tw=1&pmid=32871850 #FOAvip BACKGROUND: Antibody testing is necessary to identify immune individuals in the post-initial wave of the COVID-19 pandemic. PATIENTS AND METHODS: We prospectively evaluated the performance of a quantitative point-of-care test (POCT) for SARS-CoV-2 antibodies. The patient group (PG) comprised of hospitalized confirmed COVID-19 cases. Asymptomatic healthcare volunteers with negative rRT-PCR were included in the control group (CG). Measurement of IgM and IgG was obtained by dry fluorescence immunoassay. RESULTS: Twenty-six PG (65.9+/-15.4 years old, male 57.7%) and 18 CG (45.6+/-10.1 years old, male 33.3%) were included. By manufacturer's cut-off (>/=0.04 mIU/ml), sensitivity and specificity were 73.08% and 88.89% for IgM and 88.46% and 33.33% for IgG, respectively. Estimated areas under the ROC curve were 0.907 and 0.848 for IgM and IgG, respectively. Results were improved using a cut-off of IgM >/=0.05 mIU/ml and IgG >/=0.10 mIU/ml. CONCLUSION: Using stringent cut-off values, SARS-CoV-2 antibody POCT detects immune people and can be used during socioeconomic normalization of communities. Twit Text FOAVip Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece ????In Vivo http://www.kidney.de/pget.php?&tw=1&pmid=32871850 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32871850 #FOAvip English Wikipedia <ref>{{Cite pmid|32871850}}</ref> Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 Antibodies From Greece #MMPMID32871850 Fragkou PC; Papaevangelou V; Antoniadou A; Kavvatha D; Ploussi A; Pantazis N; Sirmpilantze T; Psarrakis C; Pournaras SA; Tsiodras S; Kelekis A In Vivo 2020[Sep]; 34 (5): 3039-3045 PMID32871850show ga BACKGROUND: Antibody testing is necessary to identify immune individuals in the post-initial wave of the COVID-19 pandemic. PATIENTS AND METHODS: We prospectively evaluated the performance of a quantitative point-of-care test (POCT) for SARS-CoV-2 antibodies. The patient group (PG) comprised of hospitalized confirmed COVID-19 cases. Asymptomatic healthcare volunteers with negative rRT-PCR were included in the control group (CG). Measurement of IgM and IgG was obtained by dry fluorescence immunoassay. RESULTS: Twenty-six PG (65.9+/-15.4 years old, male 57.7%) and 18 CG (45.6+/-10.1 years old, male 33.3%) were included. By manufacturer's cut-off (>/=0.04 mIU/ml), sensitivity and specificity were 73.08% and 88.89% for IgM and 88.46% and 33.33% for IgG, respectively. Estimated areas under the ROC curve were 0.907 and 0.848 for IgM and IgG, respectively. Results were improved using a cut-off of IgM >/=0.05 mIU/ml and IgG >/=0.10 mIU/ml. CONCLUSION: Using stringent cut-off values, SARS-CoV-2 antibody POCT detects immune people and can be used during socioeconomic normalization of communities. |*Pandemics[MESH] |Aged[MESH] |Antibodies, Viral/blood/*isolation & purification[MESH] |Betacoronavirus/*isolation & purification/pathogenicity[MESH] |COVID-19[MESH] |Coronavirus Infections/*diagnosis/epidemiology/virology[MESH] |Greece/epidemiology[MESH] |Humans[MESH] |Immunoglobulin G/blood/isolation & purification[MESH] |Male[MESH] |Middle Aged[MESH] |Pneumonia, Viral/*diagnosis/epidemiology/virology[MESH] |Point-of-Care Systems[MESH] |SARS-CoV-2[MESH]Preliminary Data of a Quantitative Point of Care Test for SARS-CoV-2 A(epmc).pdf DeepDyve Pubget Overpricing